Dosimetric and clinical predictors of toxicity following combined chemotherapy and moderately hypofractionated rotational radiotherapy of locally advanced pancreatic adenocarcinoma
| Autor: | Michele Reni, Najla Slim, Riccardo Calandrino, Stefano Cereda, Nadia Di Muzio, Giovanni Mauro Cattaneo, Paolo Passoni, Barbara Longobardi |
|---|---|
| Přispěvatelé: | Cattaneo, Gm, Passoni, P, Longobardi, B, Slim, N, Reni, M, Cereda, S, di Muzio, N, Calandrino, R |
| Rok vydání: | 2013 |
| Předmět: |
Male
medicine.medical_specialty Adenocarcinoma Pancreatic tumor Pancreatic cancer medicine Humans Radiology Nuclear Medicine and imaging Aged Performance status business.industry Dose fractionation Induction chemotherapy Combination chemotherapy Radiotherapy Dosage Hematology Chemoradiotherapy Induction Chemotherapy medicine.disease Acute toxicity Surgery Pancreatic Neoplasms Oncology Female Radiology Dose Fractionation Radiation business |
| Popis: | Background and purpose Hypofractionated radiotherapy (RT) of pancreatic adenocarcinoma is limited by the tolerance of adjacent normal tissues. A better understanding of the influence of dosimetric variables on the rate of toxicity after RT must be considered an important goal. Methods and materials Sixty-one patients with histologically proven locally advanced disease (LAPD) were analyzed. The therapeutic strategy consisted of induction chemotherapy (ChT) followed by concurrent chemoradiotherapy (CRT). In 39 out of 61 patients the target volume was based on a four-dimensional CT (4D-CT) procedure. Delivered dose was 44.25Gy in 15 fractions to PTV 2 , which consisted of pancreatic tumor and regional lymph nodes considered radiologically involved; 23 out of 61 patients received a simultaneous integrated boost (SIB) to a tumor sub-volume infiltrating the great abdominal vessels (PTV 1 ) with dose in the range of 48–58Gy. RT was delivered with Helical Tomotherapy. Dose–volume histograms (DVHs) of target volumes and organs at risk (OARs) were collected for analysis. The predictive value of clinical/dosimetric parameters was tested by univariate/multivariate analyses. Results The crude incidence of acute gastrointestinal (GI) grade 2 toxicity was 33%. The 12-month actuarial rate of "anatomical" (gastro-duodenal mucosa damage) toxicity was 13% (95% CI: 4–22%). On univariate analysis, several stomach and duodenum DVH endpoints are predictive of toxicity after moderately hypofractionated radiotherapy. Multivariate analysis confirmed that baseline performance status and the stomach V 20 [%] were strong independent predictors of acute GI grade ⩾2 toxicity. The high-dose region of duodenum DVH ( V 45 [%]; V 40 [%]) was strongly correlated with grade ⩾2 "anatomical" toxicity; the best V 40 [%] and V 45 [%] cut-off values were 16% and 2.6% respectively. Conclusion Regarding dosimetric indices, stomach V 20 [%] correlates with a higher rate of acute toxicity; more severe acute and late anatomical toxicities are related to the high dose region of duodenum DVH. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|